Nippon Shokubai announces to Form a Capital Alliance with Rena Therapeutics

NIPPON SHOKUBAI CO., LTD. (Headquarter: Osaka, Japan, President: Yujiro Goto, hereinafter “Nippon Shokubai”) announces that Nippon Shokubai has decided to subscribe for shares of Rena Therapeutics Inc. (Headquarter: Tokyo, Japan, President: Jun Sasaki, hereinafter “Rena Therapeutics”) through a third party allotment, and today completed payment procedures.

For further information, please see the following file.